| 17.62 0.77 (4.57%) | 03-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.69 | 1-year : | 24.9 |
| Resists | First : | 19.43 | Second : | 21.32 |
| Pivot price | 17.45  |
|||
| Supports | First : | 16.37 | Second : | 13.62 |
| MAs | MA(5) : | 17.11 |
MA(20) : | 17.69 |
| MA(100) : | 19.43 |
MA(250) : | 17.21 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.8 |
| %K %D | K(14,3) : | 26.6 |
D(3) : | 17.4 |
| RSI | RSI(14): 44.4 |
|||
| 52-week | High : | 23.87 | Low : | 11.62 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ALHC ] has closed below upper band by 41.0%. Bollinger Bands are 40.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 17.86 - 17.93 | 17.93 - 18 |
| Low: | 16.75 - 16.82 | 16.82 - 16.9 |
| Close: | 17.48 - 17.6 | 17.6 - 17.74 |
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Tue, 31 Mar 2026
JPMorgan Chase & Co. Sells 87,113 Shares of Alignment Healthcare, Inc. $ALHC - MarketBeat
Tue, 31 Mar 2026
Alignment Healthcare, Inc. (NASDAQ:ALHC) Q4 2025 earnings call transcript - MSN
Thu, 26 Mar 2026
Vanguard Holdings Update — Alignment Healthcare (NASDAQ: ALHC) shows 0 shares - Stock Titan
Thu, 26 Mar 2026
CEO Planned Share Sale And Alignment Healthcare Valuation Gap - Sahm
Thu, 26 Mar 2026
A Look At Alignment Healthcare (ALHC) Valuation After Recent Share Price Weakness - Yahoo Finance
Thu, 26 Mar 2026
Tudor Investment Corp ET AL Has $4.76 Million Stake in Alignment Healthcare, Inc. $ALHC - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 204 (M) |
| Shares Float | 168 (M) |
| Held by Insiders | 3.8 (%) |
| Held by Institutions | 101.8 (%) |
| Shares Short | 15,900 (K) |
| Shares Short P.Month | 16,060 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.87 |
| Profit Margin | -0.1 % |
| Operating Margin | -1.1 % |
| Return on Assets (ttm) | 1.1 % |
| Return on Equity (ttm) | -0.7 % |
| Qtrly Rev. Growth | 44.4 % |
| Gross Profit (p.s.) | 2.39 |
| Sales Per Share | 19.33 |
| EBITDA (p.s.) | 0.22 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 140 (M) |
| Levered Free Cash Flow | 125 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 20.02 |
| Price to Sales | 0.91 |
| Price to Cash Flow | 25.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|